Explore more publications!

Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on September 18, 2025

SmartGraft® by Vision Medical Expands Global Reach with New Distribution in Armenia and India.
Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs’ REMONY for Advanced Health Monitoring and Heatstroke Safety
Vulvar Cancer Market Size to Reach USD 1237.09 Bn by 2032 | Global Growth at 7.0% CAGR (2024–2032)
DBV Technologies Announces Resignation of Board Member
DBV Technologies annonce la démission d’un membre de son Conseil d’administration
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
Jasper Therapeutics Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Palisade Bio Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
iCare ABA Therapy Launches With AI-Supported Model, Sparks Industry Debate on AI’s Role in Autism Care
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Veterinary CRO and CDMO Market Size Worth USD 13.65 Bn by 2032 | Global Growth at 9.2% CAGR (2024–2032)
Compass Health Celebrates Grand Opening of Marc Healing Center
Ceramics Industry Set for Strong Growth, Projected to Reach $62.5 Billion by 2030
Alameda Health System is recognized for responsible sourcing and sustainable procurement
Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed/refractory AL Amyloidosis Clinical Trial, NEXICART-2
Chronic Venous Insufficiency Market to Increase at a CAGR of 9.4% During the Forecast Period (2025–2034) Due to the Launch of Emerging Therapies and Chronic Venous Insufficiency Medical Devices | DelveInsight

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions